G. Bradley Cole, Director at Kiniksa Pharmaceuticals International, plc (KNSA), sold 8,173 shares at $81.43 ($299K) on 2026-07-29, disclosed to the SEC on 2026-07-31.
Open-market sale of $299k KNSA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 4,500 | $0 | 0.0% |
| 2 | $81.43 | 3,673 | $299K | 100.0% |
| Total | $36.60 avg | 8,173 | $299K | 100% |
| Filing → |
| EXAS | SELL | 2020-01-17 | $903K | — | Filing → |
| EXAS | SELL | 2019-11-25 | $4.5M | — | Filing → |
| GHDX | SELL | 2019-10-09 | $3.1M | — | Filing → |